Clinical Trial Details

Trial ID: L0554
Source ID: JPRN-UMIN000026635
Associated Drug: Lubiprostone
Title: Efficacy Evaluation of Lubiprostone on Non-Alcoholic Fatty Liver Disease (NAFLD)wih constipation: LUBIPRONE, Proof of Concept(POC) Study. - LUBIPRONE, Proof of Concept(POC) Study.
Acronym: --
Status: Not Recruiting
Study Results: No Results Available
Results: --
Conditions: Non-Alcoholic Fatty Liver Disease (NAFLD) in Constipated Patients
Interventions: Placebo<br>Lubiprostone<br>12 mcg group<br><br>Lubiprostone<br>24 mcg group
Outcome Measures: Change from baseline in ALT at Week 12nan
Sponsor/Collaborators: Yokohama University School of Medicine
Gender: All
Age: 20years-old85years-old
Phases: Not selected
Enrollment: 150
Study Type: Interventional
Study Designs: Parallel Randomized
Start Date: 22/03/2017
Completion Date: 01/10/2018
Results First Posted: --
Last Update Posted: 27 September 2021
Locations: Japan
URL: https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030584